Vanda Pharmaceuticals (VNDA) Adopts Limited Duration Stockholder Rights Plan

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/13/2026

1. MIRM
2. SPY
3. META
4. MSFT
5. JNJ
6. PLTR
7. QQQ
8. LDOS
9. AXP
10. AON

Go back to Vanda Pharmaceuticals (VNDA) Adopts Limited Duration Stockholder Rights Plan

Vanda Pharmaceuticals (VNDA) Confirms Rejection of Unsolicited Takeover Proposals from Future Pak

April 17, 2024 9:07 AM EDT

Vanda Pharmaceuticals Inc. ("Vanda" or the "Company") (Nasdaq: VNDA) today confirmed that, since March 2024, it received several unsolicited proposals from Future Pak, LLC ("Future Pak"), to acquire all of the outstanding shares of Vanda (the "Conditional Proposals"). The most recent... More

Future Pak Confirms Proposal to Acquire Vanda Pharmaceuticals (VNDA) for $7.25-$7.75/sh Cash

April 17, 2024 6:31 AM EDT

Future Pak LLC (Future Pak) today announced that it has submitted three proposals since February to acquire all of the outstanding shares of common stock of Vanda Pharmaceuticals, Inc. (Vanda) (NASDAQ: VNDA), and confirms that its most recent proposal to acquire Vanda for cash consideration of $7.25 to $7.75 per share remains open for Vanda and its Board of Directors to consider.

The current proposal implies a... More